One third of adults with CF have diabetes. This trial tests a hybrid closed loop system compared to standard care with insulin. Outcome: glucose time-in-range. Thanks to NIHR. Inst Metabolic Science-Metabolic Research Labs OCDEM Cystic Fibrosis Trust Charlotte Boughton We are NIHR

A big milestone today Oxford Psychiatry as we complete the first randomisation visit for the ISAP trial. My thanks to the study participants, CRF team (represented by Amanda and Rachel), the Oxford Diabetes Trial Unit Amanda I Adler , Dementias Platform UK, Oxford Health Biomedical Research Centre, and Novo Nordisk

For #WorldDiabetesDay, we are sharing Elly's story. She is the first person recruited to a study at Cambridge University Hospitals NHS aiming to improve glucose management & reduce the treatment burden for people with cystic fibrosis-related diabetes. Be Part of Research Read more: local.nihr.ac.uk/news/im-a-real…

The World Health Organization (WHO) Global Diabetes Compact wishes you all a Happy #WorldDiabetesDay! Learn more about how the Compact is trying to get to a world where PLWD have access to equitable, comprehensive, affordable and quality treatment and care who.int/initiatives/th…

Good summary of their findings and implications nature.com/articles/s4301… Nature Food Amanda I Adler Rhea Saksena University of Oxford

The UK’s first registry for those at risk of #type1diabetes will be held at our Diabetes Trials Unit. The registry will improve understanding of the care and support required by those at risk of this condition.

We are thrilled to announce that our CEO, Prof Rory Collins has been chosen to feature in the first ever #TIME100HEALTH list, recognising the extraordinary impact of his leadership at UK Biobank. Read Rory’s interview with TIME here time.com/6962873/rory-c…

Does the tendency of clinical commissioning groups (CCGs) in England to prescribe different 2nd line agents in diabetes vary 'naturally'? We thought so. Patrick Bidulka David Lugo Palacios Orlagh Carroll Anirban Basu Prof Kamlesh Khunti Stephen O'Neill Richard Silverwood Jonathan Bartlett Liam Smeeth

Post-trial monitoring of a randomised controlled trial of intensive gl... sciencedirect.com/science/articl… UKPDS - Early good blood glucose control in type 2 diabetes has near lifelong benefits. University of Oxford The University of Edinburgh

UKPDS- the gift that keeps on giving. Metabolic memory shows no effect of waning! #type2diabetes

Congratulations to the research midwives and team at Chelsea and Westminster Hospital on recruiting their first participant! That makes 14 😀 Can we get 2 more to meet our target of 16 by the end of May??

Was an honour to deliver the 33rd Joint London School of Hygiene & Tropical Medicine - Royal Statistical Society Perspectives on Statistics in Medicine Annual Lecture today MRC Clinical Trials Unit at UCL ICTM at UCL

Can we use synthetic data to smooth getting new treatments to people? Come find out REDDIEdiabetes

Your yearly reminder that “We need less research, better research, and research done for the right reasons” #OTD 1948 Douglas Altman b (d 3 June 2018)🇬🇧 A brilliant statistics educator & “one of the most influential medical statisticians of the past 50 years” /5

Please join us for the 🔥hot 🔥topic of synthetic data with its potential to assess clinical and cost effectiveness faster, if not also better. RDM Oxford The University of Edinburgh The University of Manchester University of Warwick NICE University of Liverpool MHRAgovuk Novo Nordisk Università di Padova Horizon Europe🇪🇺 and others

🧐Job opening at #REDDIE University of Leicester is looking for a Research Associate in Statistics. The position is open within the 🌱Leicester Diabetes and is led by Pratik Choudhary. Check out the job position via the link or share it with someone who might be interested. 👉 bit.ly/3YjbZNU

Finally! 4 years after scientific fraud & politicised science derailed it, #COPCOV, the world’s largest COVID-19 chemoprevention study, published results today in PLOS Medicine: Hydroxychloroquine (HCQ) does have a moderate benefit in preventing #COVID-19 bit.ly/3XGdeGl

Missed our first #REDDIE webinar on synthetic data for regulatory and payer purposes? Read about it in the article and watch the full session from the keynote speaker, Prof. Gillian Raab. 👇 reddie-diabetes.eu/news/synthetic… #SyntheticData #Webinar #RWD #HorizonEU

Metformin in prostate cancer in a controlled trial with overall survival as the endpoint, and with metabolic secondary endpoints.